June 2015
Volume 56, Issue 7
ARVO Annual Meeting Abstract  |   June 2015
Real-time in vivo visualization of induced retinal oxidative stress and the effect of antioxidants
Author Affiliations & Notes
  • Nigel L Barnett
    Queensland Eye Institute, South Brisbane, QLD, Australia
    University of Queensland, Brisbane, QLD, Australia
  • Glen A Gole
    University of Queensland, Brisbane, QLD, Australia
  • Cassie Leigh Rayner
    Queensland Eye Institute, South Brisbane, QLD, Australia
  • Steven Eric Bottle
    Queensland University of Technology, Brisbane, QLD, Australia
  • Footnotes
    Commercial Relationships Nigel Barnett, None; Glen Gole, None; Cassie Rayner, None; Steven Bottle, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 171. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Nigel L Barnett, Glen A Gole, Cassie Leigh Rayner, Steven Eric Bottle; Real-time in vivo visualization of induced retinal oxidative stress and the effect of antioxidants. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):171.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

To quantify in real-time the antioxidant properties of novel nitroxide compounds administered after an in vivo pro-oxidant stress.


We employ a novel mitochondrially-targeted profluorescent nitroxide (PFN) probe that is reversibly responsive to general cellular redox status. Following intraocular injection of the PFN probe (2 µM in DMSO), unilateral acute retinal ischaemia was induced in anaesthetized Sprague-Dawley rats by elevation of intraocular pressure (IOP, 120mmHg 60min). After restoration of normal IOP, retinal fluorescence (556nm/590nm) was assessed at various time-points (up to 60 mins) during reperfusion with a Micron rodent fundus camera. Nitroxide antioxidant compounds (5-carboxy-1,1,3,3-tetramethylisoindolin-2-yloxyl, CTMIO or 5,6-dicarboxy-1,1,3,3-tetraethylisoindolin-2-yloxyl, DCTEIO, 100 µM in 2 µl, or vehicle DMSO) were injected intravitreally after 30 mins of reperfusion and retinal fluorescence monitored for a further 30 mins. Changes in fluorescence, which reflect retinal oxidative status, were quantified and compared with those measured before antioxidant administration. Control fluorescence time-course data were obtained from the non-ischaemic contralateral eyes. The effects of the novel nitroxide antioxidants (n=6) were compared with the known antioxidant compound, resveratrol (100 µM, 2 µl, n=6).


We previously showed that post-ischaemic reperfusion (I/R), which stimulates free radical production, induces a marked decrease in retinal PFN fluorescence (ARVO 2014). Here, we show that intraocular administration of CTMIO or DCTEIO reverses the I/R-induced decrease in retinal fluorescence, as reported by the PFN probe: CTMIO induced a 66±14% reversal, DCTEIO 90±18% reversal. In comparison, the recognised antioxidant resveratrol reversed the I/R-induced decrease in retinal fluorescence by 50±12%. Neither DMSO nor the nitroxide antioxidants significantly altered the fluorescence intensity in non-I/R retinas.


We have demonstrated in vivo, that two potent nitroxide antioxidants effect a real-time reversal of oxidative stress in the retina. Through the use of our novel, reversibly-responsive probe for oxidative stress, we have provided the first evidence that antioxidants such as these hold potential to protect the retina from the deleterious consequences associated with diseases that involve oxidative stress.  


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.